Close log in window
Clinical trial sponsors need to work closely with patients to establish study designs that meet patient needs – from endpoints to what dec...
Although cell and gene therapies (CGTs) are typically expensive products, there are techniques that pharmaceutical companies can execute to ...
Clinical trial sponsors should implement multiple approaches to boost diversity in studies, from ensuring collected data reflect participant...
Since there is still relatively limited precedence to cell and gene therapy (CGT) manufacturing, there are many opportunities for improvemen...